Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Perrigo Company PLC Stock Research

PRGO

32.25USD-0.43(-1.32%)Market Closed
Watchlist

Market Summary

USD32.25-0.43
Market Closed
-1.32%

PRGO Alerts

  • Big jump in Earnings (Y/Y)

PRGO Stock Price

PRGO RSI Chart

PRGO Valuation

Market Cap

4.4B

Price/Earnings (Trailing)

-64.45

Price/Sales (Trailing)

0.94

Price/Free Cashflow

19.26

PRGO Price/Sales (Trailing)

PRGO Profitability

Return on Equity

-2.92%

Return on Assets

-1.29%

Free Cashflow Yield

5.19%

PRGO Fundamentals

PRGO Revenue

Revenue (TTM)

4.6B

Revenue Y/Y

6.37%

Revenue Q/Q

0.96%

PRGO Earnings

Earnings (TTM)

-67.7M

Earnings Y/Y

112.9%

Earnings Q/Q

380%

Price Action

52 Week Range

30.7841.15
(Low)(High)

Last 7 days

-3.8%

Last 30 days

-14.9%

Last 90 days

-3.8%

Trailing 12 Months

-16.5%

PRGO Financial Health

Current Ratio

2.52

PRGO Investor Care

Dividend Yield

2.19%

Dividend/Share (TTM)

0.71

Shares Dilution (1Y)

0.52%

Diluted EPS (TTM)

-0.5

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for PRGO

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-15
Manzone Albert
sold (taxes)
-102,254
38.88
-2,630
-
2023-08-15
Manzone Albert
acquired
212,985
38.88
5,478
-
2023-07-07
HANSON KYLE
sold (taxes)
-118,871
32.63
-3,643
evp & general counsel
2023-07-07
HANSON KYLE
acquired
404,906
32.63
12,409
evp & general counsel
2023-07-07
Ives Alison
sold (taxes)
-8,842
32.63
-271
evp & chief scientific officer
2023-07-07
Ives Alison
acquired
30,019
32.63
920
evp & chief scientific officer
2023-06-13
Parker Geoffrey M.
bought
330,637
33.0637
10,000
-
2023-06-07
Bezerra Eduardo Guarita
acquired
152,819
33.72
4,532
evp & chief financial officer
2023-06-07
Bezerra Eduardo Guarita
sold (taxes)
-37,226
33.72
-1,104
evp & chief financial officer
2023-05-23
Andersen Svend
bought
96,902
33.4146
2,900
evp & president chci

1–10 of 50

Which funds bought or sold PRGO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-21
Jefferies Group LLC
new
-
138,753
138,753
-%
2023-09-20
BARCLAYS PLC
added
147
2,088,000
3,640,000
-%
2023-09-12
Farther Finance Advisors, LLC
sold off
-100
-1,291
-
-%
2023-08-25
Gould Capital, LLC
unchanged
-
-13.00
238
-%
2023-08-23
Stonebridge Capital Advisors LLC
unchanged
-
-19.00
340
-%
2023-08-23
Dean Capital Management
reduced
-21.14
-155,730
458,257
0.61%
2023-08-22
Asset Dedication, LLC
unchanged
-
-1,000
5,000
-%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
10.3
34,000
807,000
0.01%
2023-08-21
OSAIC HOLDINGS, INC.
reduced
-18.64
-526,340
1,761,360
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-2.52
-471,987
5,625,450
0.01%

1–10 of 46

Latest Funds Activity

Are funds buying PRGO calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own PRGO
No. of Funds

Schedule 13G FIlings of Perrigo Company

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 15, 2023
barrow hanley mewhinney & strauss llc
7.30%
9,825,539
SC 13G
Feb 14, 2023
price t rowe associates inc /md/
0.1%
78,305
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
0.1%
78,305
SC 13G/A
Feb 09, 2023
vanguard group inc
10.84%
14,590,276
SC 13G/A
Jan 24, 2023
blackrock inc.
9.8%
13,221,594
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
8.0%
10,721,574
SC 13G/A
Feb 03, 2022
blackrock inc.
8.6%
11,557,239
SC 13G/A
Jan 10, 2022
barrow hanley mewhinney & strauss llc
10.10%
13,505,133
SC 13G
Nov 10, 2021
price t rowe associates inc /md/
8.4%
11,328,393
SC 13G/A
Sep 10, 2021
price t rowe associates inc /md/
18.0%
24,135,892
SC 13G/A

Recent SEC filings of Perrigo Company

View All Filings
Date Filed Form Type Document
Sep 20, 2023
3
Insider Trading
Sep 11, 2023
8-K
Current Report
Aug 17, 2023
4
Insider Trading
Aug 09, 2023
8-K
Current Report
Aug 08, 2023
8-K
Current Report
Aug 08, 2023
10-Q
Quarterly Report
Jul 12, 2023
4
Insider Trading
Jul 10, 2023
4
Insider Trading
Jul 10, 2023
4
Insider Trading
Jul 07, 2023
3
Insider Trading

Peers (Alternatives to Perrigo Company)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
495.3B
29.5B
-0.51% 77.59%
76.23
16.78
1.53% 14.16%
417.0B
97.8B
-1.74% -2.10%
31.95
4.27
2.29% -28.92%
272.8B
58.3B
-4.46% 23.17%
17.88
4.63
2.00% -81.24%
184.6B
77.9B
-10.83% -26.03%
8.6
2.37
-23.04% -26.74%
150.1B
45.2B
-4.32% -16.75%
23.72
3.25
-4.15% 20.34%
MID-CAP
6.5B
-
1.87% 616.21%
-74.09
4.1K
-86.94% 71.24%
4.4B
4.6B
-14.86% -16.47%
-64.45
0.94
6.60% 42.04%
SMALL-CAP
1.6B
627.1M
-7.75% -14.29%
-1.08
2.51
-0.20% -204.67%
1.5B
634.0M
-12.24% -14.48%
35.26
2.41
0.62% -24.59%
841.4M
244.3M
-2.86% 8.68%
4.27
3.44
-39.50% -4.99%
792.7M
109.5M
17.51% -27.27%
-5.52
7.24
-2.66% -32.13%
470.6M
31.2M
-8.53% -51.99%
-4.47
15.1
407.54% -26.47%
462.3M
453.3M
100.98% -69.12%
-0.38
1.02
-16.04% 55.90%
252.8M
54.6M
-17.14% -44.23%
-2.79
4.63
9.39% -179.16%
-
2.2B
- -
-
-
-22.39% 63.59%

Perrigo Company News

MarketBeat
Copeland Capital Management LLC Has $69.57 Million Stake in ....
MarketBeat,
39 hours ago
Clayton County Register
Duality Advisers LP Buys Stake in Perrigo Company.
Clayton County Register,
5 days ago
Yahoo Finance
Perrigo Announces Leadership Update.
Yahoo Finance,
13 days ago

Returns for PRGO

Cumulative Returns on PRGO

-11.7%


10-Year Cumulative Returns

-13.5%


7-Year Cumulative Returns

-13.9%


5-Year Cumulative Returns

-10.3%


3-Year Cumulative Returns

Risks for PRGO

What is the probability of a big loss on PRGO?

89.6%


Probability that Perrigo Company stock will be more than 20% underwater in next one year

37.7%


Probability that Perrigo Company stock will be more than 30% underwater in next one year.

18.9%


Probability that Perrigo Company stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does PRGO drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Perrigo Company was unfortunately bought at previous high price.

Drawdowns

Financials for Perrigo Company

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue1.6%4,6304,5594,4524,4014,3444,2034,1394,3234,2844,2514,3254,3584,5464,7464,8374,7104,6524,6894,7324,8204,918
Gross Profit3.7%1,5871,5311,4551,4351,4091,3861,4161,5231,5561,5551,5801,5921,6351,7181,7731,7351,7471,7881,8321,9011,974
Operating Expenses-0.5%1,4181,4261,3771,3419091,0051,0061,0371,4301,2401,2301,0611,1281,2201,2591,4161,6051,6051,5951,6141,402
  S&GA Expenses3.3%637617585562548537536562562541546505509530539567568583596596604
  R&D Expenses0.6%12612512312111912012212512812512280.0094.00107119173172220219221216
EBITDA--------501522541544551559560565561564576586--
EBITDA Margin--------0.12*0.12*0.11*0.11*0.11*0.11*0.11*0.12*0.12*0.12*0.12*0.12*--
Interest Expenses-3.5%-169-163-156-145-135-128-125-127-130-130-127-121-118-117-117-123-124-125-128-130-133
Earnings Before Taxes-------------------291--
EBT Margin--------0.07*0.06*0.06*0.06*0.06*0.06*0.06*0.06*0.06*0.06*0.06*0.06*--
Net Income52.1%-67.70-141-140-107-116-109-68.90-253-349-230-162-6.6024018914624787.00114131123235
Net Income Margin100.0%--0.03*-0.03*-0.02*-0.03*-0.03*-0.02*-0.06*-0.08*-0.05*-0.03*0.00*0.05*0.04*0.03*------
Free Cashflow-100.0%-148211-95.701681084.00196-87.30283466464549315250------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets0.1%10,96510,95511,01710,67810,92010,39010,42610,91611,23011,32511,48811,57612,12811,40111,30111,31111,42911,12010,98310,94311,226
  Current Assets1.2%2,7732,7412,7202,5832,6523,9363,8604,2264,4204,4893,1343,3983,8043,0462,7312,7403,4353,0092,9022,7692,779
    Cash Equivalents0.4%5555536014694851,9661,8652,0783184716328401,4384923453991,056838542444527
  Inventory-1.3%1,1681,1831,1501,0851,0801,0221,0201,0931,1161,1361,0591,1011,035931967991941913878885884
  Net PPE-0.1%918919926840840846864843834860865919892889774871824821829820812
Liabilities-0.1%6,1166,1216,1756,0756,0705,2855,2745,7345,7195,7675,8335,7566,2175,6145,4975,5525,7025,4195,3155,2835,328
  Current Liabilities-2.8%1,0571,0871,1141,0151,0159811,5882,0041,9851,4471,3821,3361,8601,6351,3361,3251,7911,8321,5371,4941,538
    LT Debt, Current-1.0%38.0039.0036.0034.0031.005.0060462963036.0037.0017.006072883.003.00399468190194198
    LT Debt, Non Current-0.2%4,0564,0634,0704,0784,0863,5112,9172,9212,9263,5253,5283,5443,5363,1833,3663,3623,0842,7503,0523,0713,085
Shareholder's Equity0.3%4,8494,8344,8424,6034,8505,1055,1525,1825,5115,5585,6555,8205,9105,7865,8045,7595,7265,7015,6685,6605,897
  Retained Earnings0.4%-2,062-2,070-2,067-2,043-1,994-1,929-1,927-1,936-1,877-1,820-1,858-1,683-1,528-1,589-1,695-1,676-1,768-1,777-1,838-1,919-1,852
Shares Outstanding0.3%135135-135135134-134134133135137136136136136136136136137138
Minority Interest------------0.001.001.000.000.000.000.000.000.000.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations28.2%31724830716.0030123515637291.00465636615692465388493497515593616668
  Share Based Compensation14.2%61.0054.0055.0057.0058.0061.0060.0065.0068.0067.0059.0055.0054.0056.0052.0052.0043.0037.0038.0042.0051.00
Cashflow From Investing96.5%-70.90-2,040-1,958-1,974-5001,4531,2761,190-301-227-187-166-779-901-596-53564.00105-126-14.7027.00
Cashflow From Financing-143.7%-184423422406413-187-178-322-932-289-181-11.204901082.00-1.00-31.50-450-571-921-918
  Dividend Payments1.1%14614414213913413113012912712612412212011711211010710410510198.00
  Buy Backs-----------1644.00-----292400400398

PRGO Income Statement

2023-07-01
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended6 Months Ended
Jul. 01, 2023
Jul. 02, 2022
Jul. 01, 2023
Jul. 02, 2022
Income Statement [Abstract]    
Net sales$ 1,193.1$ 1,121.7$ 2,374.8$ 2,196.2
Cost of sales765.1749.61,532.91,486.3
Gross profit428.0372.1841.9709.9
Operating expenses    
Distribution28.629.557.253.9
Research and development32.231.563.360.8
Selling171.1150.8339.0286.4
Administration132.6157.8267.6280.1
Restructuring6.79.510.213.1
Other operating (income) expense, net0.0(0.1)(0.8)0.8
Total operating expenses371.2379.0736.5695.1
Operating income (loss)56.8(6.9)105.414.8
Interest expense, net44.038.387.674.1
Other (income) expense, net(9.7)53.8(9.0)52.7
Loss on extinguishment of debt0.09.30.09.3
Income (loss) from continuing operations before income taxes22.5(108.3)26.8(121.3)
Income tax expense (benefit)13.6(43.4)19.0(55.1)
Income (loss) from continuing operations8.9(64.9)7.8(66.2)
Income (loss) from discontinued operations, net of tax(0.5)(0.2)(2.4)(1.4)
Net income (loss)$ 8.4$ (65.1)$ 5.4$ (67.6)
Basic    
Continuing operations (in dollars per share)$ 0.07$ (0.48)$ 0.06$ (0.49)
Discontinued operations (in dollars per share)00(0.02)(0.01)
Basic earnings (loss) per share (in dollars per share)0.06(0.48)0.04(0.50)
Diluted    
Continuing operations (in dollars per share)0.06(0.48)0.06(0.49)
Discontinued operations (in dollars per share)00(0.02)(0.01)
Diluted earnings (loss) per share (in dollars per share)$ 0.06$ (0.48)$ 0.04$ (0.50)
Weighted-average shares outstanding    
Basic (in shares)135.3134.6135.1134.3
Diluted (in shares)136.6134.6136.5134.3

PRGO Balance Sheet

2023-07-01
Condensed Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Jul. 01, 2023
Dec. 31, 2022
Assets  
Cash and cash equivalents$ 555.2$ 600.7
Accounts receivable, net of allowance for credit losses of $8.1 and $6.8, respectively754.1697.1
Inventories1,167.51,150.3
Prepaid expenses and other current assets296.2271.8
Total current assets2,773.02,719.9
Property, plant and equipment, net918.3926.3
Operating lease assets206.9217.1
Goodwill and indefinite-lived intangible assets3,657.83,549.0
Definite-lived intangible assets, net3,030.83,230.2
Deferred income taxes6.37.1
Other non-current assets371.6367.7
Total non-current assets8,191.78,297.4
Total assets10,964.711,017.3
Liabilities and Shareholders’ Equity  
Accounts payable470.5537.3
Payroll and related taxes104.4136.4
Accrued customer programs174.3139.1
Other accrued liabilities261.7250.2
Accrued income taxes7.614.4
Current indebtedness38.436.2
Total current liabilities1,056.91,113.6
Long-term debt, less current portion4,055.94,070.4
Deferred income taxes344.6368.2
Other non-current liabilities658.7623.0
Total non-current liabilities5,059.25,061.6
Total liabilities6,116.16,175.2
Contingencies - Refer to Note 16
Controlling interests:  
Preferred shares, $0.0001 par value per share, 10 shares authorized0.00.0
Ordinary shares, €0.001 par value per share, 10,000 shares authorized6,890.96,936.7
Accumulated other comprehensive income19.9(27.0)
Retained earnings (accumulated deficit)(2,062.2)(2,067.6)
Total shareholders’ equity4,848.64,842.1
Total liabilities and shareholders' equity$ 10,964.7$ 11,017.3
Supplemental Disclosures of Balance Sheet Information  
Preferred shares, issued and outstanding (in shares)0.00.0
Ordinary shares, issued and outstanding (in shares)135.4134.7
Murray S. Kessler
9900
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.